Time course of myocardial necrosis Jutta SchaperWolfgang Schaper Part Two: Basic Concept Pages: 17 - 25
Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapy Eberhard BassengeDuncan J. Stewart Part Two: Basic Concept Pages: 27 - 34
Pathophysiology of myocardial ischemia: Importance of platelet-vessel wall interactions James Roy Parratt Part Two: Basic Concept Pages: 35 - 40
Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography Luis I. AraujoPaolo CamiciAttilio Maseri Part Two: Basic Concept Pages: 41 - 46
The combination of antianginal drugs: Effects and indications Paul Robert Lichtlen Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 47 - 60
Silent ischemia: A relevant problem in patients with coronary artery disease? W. RutishauserA. RighettiP. Roy Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 61 - 65
Indications for treatment of silent myocardial ischemia Peter F. Cohn Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 67 - 69
Nonresponsiveness to antianginal therapy—A frequent problem? Wolfgang Schulz Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 71 - 77
Preload or afterload reduction: Which is more beneficial for patients with ischemic heart disease? Dennis G. CaralisZ. Kyriakides Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 79 - 82
Combination of positive inotropic and vasodilating substances in congestive heart failure Ivano CantelliDaniele Bracchetti Part Three: The Clinical Aspect Of Myocardial Ischemia Pages: 83 - 91
Indications for coronary angioplasty in acute myocardial ischemic syndromes Pim J. de FeyterPatrick W. SerruysPaul G. Hugenholtz Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 93 - 101
Which role for antiplatelet and anticoagulant drugs in unstable angina pectoris? H. Daniel Lewis Jr Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 103 - 106
Additional molsidomine in refractory unstable angina pectoris O. BertelG. Noll Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 107 - 111
According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction? John K. Kjekshus Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 113 - 119
What is established in thrombolytic therapy of acute myocardial infarction? Pharmacological approaches Wolfgang KüblerChristoph BodeFranz Schwarz Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 121 - 125
The influence of molsidomine on infarct size: An acute post-infarction pilot study with 303 patients P. BeaufilsH. KolskyR. Slama Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 127 - 132
Risk factor intervention and prognosis after acute myocardial infarction G Lamm Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 133 - 137
Secondary prevention after myocardial infarction: Effects of beta blocking agents and calcium antagonists P. DepelchinJ. SobolskiC. Flament Part Four: Unstable Angina And Acute Myocardial Infarction Pages: 139 - 147